Wird geladen...
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
Temozolomide (TMZ) is an oral alkylating agent that is considered the standard therapy in primary intracranial malignancies. The medication is well tolerated with a most common side effect of bone marrow suppression that is encountered in a small proportion of patients, often reversible with medicat...
Gespeichert in:
| Veröffentlicht in: | Case Rep Oncol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
S. Karger AG
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7670352/ https://ncbi.nlm.nih.gov/pubmed/33250738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509744 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|